COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program

      Study objectives

      To determine the relationship between diagnosed and treated COPD and the incidence of cardiovascular disease (CVD) hospitalization and mortality.


      Retrospective matched cohort study.


      Northern California Kaiser Permanente Medical Care Program (KPNC), a comprehensive prepaid integrated health-care system.

      Patients or participants

      Case patients (n = 45,966) were all KPNC members with COPD who were identified during a 4-year period from January 1996 through December 1999. An equal number of control subjects without COPD were selected from KPNC membership and were matched for gender, year of birth, and length of KPNC membership.

      Measurements and results

      Follow-up conducted for hospitalization and mortality from CVD end points through December 31, 2000. CVD study end points included cardiac arrhythmias, angina pectoris, acute myocardial infarction, congestive heart failure (CHF), stroke, pulmonary embolism, all of the aforementioned study end points combined, other CVD, and all CVD end points. The mean follow-up time was 2.75 years for case patients and 2.99 years for control subjects. The risk of hospitalization was higher in COPD case patients than in control subjects for all CVD hospitalization and mortality end points. The relative risk (RR) for hospitalization for the composite measure of all study end points was 2.09 (95% confidence interval [CI], 1.99 to 2.20) after adjustment for gender, preexisting CVD study end points, hypertension, hyperlipidemia, and diabetes, and ranged from 1.33 (stroke) to 3.75 (CHF). The adjusted RR for mortality for the composite measure of all study end points was 1.68 (95% CI, 1.50 to 1.88), ranging from 1.25 (stroke) to 3.53 (CHF). Younger patients (ie, age < 65 years) and female patients had higher risks than older and male participants.


      COPD was a predictor of CVD hospitalization and mortality over an average follow-up time of nearly 3 years. The finding of a stronger relationship of COPD to CVD outcomes in patients < 65 years of age suggests that CVD risk should be monitored and treated with particular care in younger adults with COPD.



      AMI (acute myocardial infarction), CHF (congestive heart failure), CI (confidence interval), CVD (cardiovascular disease), ICD-9 (International Classification of Diseases, ninth revision), ICD-10 (International Classification of Diseases, 10th revision), KPNC (Northern California Kaiser Permanente Medical Care Program), MI (myocardial infarction), OR (odds ratio), RR (relative risk), VF (ventricular fibrillation), VT (ventricular tachycardia)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Heart disease and stroke statistics: 2004 update. 2003; (American Heart Association American Heart Association. Dallas, TX)
      2. (American Lung Association. Chronic obstructive pulmonary disease (COPD) fact sheet. Available at: Accessed September 19, 2004)
        • Dankner R
        • Goldbourt U
        • Boyko V
        • et al.
        Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease: BIP Study Group.
        Am J Cardiol. 2003; 91: 121-127
        • Behar S
        • Panosh A
        • Reicher-Reiss H
        • et al.
        Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction: SPRINT Study Group.
        Am J Med. 1992; 93: 637-641
        • Islamoglu F
        • Reyhanoglu H
        • Berber O
        • et al.
        Predictors of outcome after coronary artery bypass grafting in patients older than 75 years of age.
        Med Sci Monit. 2003; 9: CR369-CR376
        • Samuels LE
        • Kaufman MS
        • Morris RJ
        • et al.
        Coronary artery bypass grafting in patients with COPD.
        Chest. 1998; 113: 878-882
        • Poulsen SH
        • Noer I
        • Moller JE
        • et al.
        Clinical outcome of patients with suspected pulmonary embolism: a follow-up study of 588 consecutive patients.
        J Intern Med. 2001; 250: 137-143
        • Engstrom G
        • Hedblad B
        • Valind S
        • et al.
        Increased incidence of myocardial infarction and stroke in hypertensive men with reduced lung function.
        J Hypertens. 2001; 19: 295-301
        • Truelsen T
        • Prescott E
        • Lange P
        • et al.
        Lung function and risk of fatal and non-fatal stroke: the Copenhagen City Heart Study.
        Int J Epidemiol. 2001; 30: 145-151
        • Ryan G
        • Knuiman MW
        • Divitini ML
        • et al.
        Decline in lung function and mortality: the Busselton Health Study.
        J Epidemiol Community Health. 1999; 53: 230-234
        • Buch P
        • Friberg J
        • Scharling H
        • et al.
        Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study.
        Eur Respir J. 2003; 21: 1012-1016
        • Krieger N
        Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.
        Am J Public Health. 1992; 82: 703-710
      3. National Institutes of Health, National Heart, Lung and Blood Institute.
        Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO workshop report. 2001; (National Institutes of Health. Bethesda, MD:; publication No. 2701)
        • Ruo B
        • Capra AM
        • Jensvold NG
        • et al.
        Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study.
        J Am Coll Cardiol. 2004; 43: 436-437
        • Trupin L
        • Earnest G
        • San Pedro M
        • et al.
        The occupational burden of chronic obstructive pulmonary disease.
        Eur Respir J. 2003; 22: 462-469
        • Eisner MD
        • Yelin EH
        • Trupin L
        • et al.
        The influence of chronic respiratory conditions on health status and work disability.
        Am J Public Health. 2002; 92: 1506-1513
      4. Centers for Disease Control and Prevention. Cigarette smoking among adults: United States, 1998.
        MMWR Morb Mortal Wkly Rep. 2000; 49: 881-884
        • Oudijk EJ
        • Lammers JW
        • Koenderman L
        Systemic inflammation in chronic obstructive pulmonary disease.
        Eur Respir J Suppl. 2003; 46: 5s-13s
        • Bucchioni E
        • Kharitonov SA
        • Allegra L
        • et al.
        High levels of interleukin-6 in the exhaled breath condensate of patients with COPD.
        Respir Med. 2003; 97: 1299-1302
        • Gan WQ
        • Man SF
        • Senthilselvan A
        • et al.
        Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
        Thorax. 2004; 59: 574-580
        • Ridker PM
        • Rifai N
        • Rose L
        • et al.
        Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
        N Engl J Med. 2002; 347: 1557-1565
        • Davis PH
        • Hachinski V
        Epidemiology of cerebrovascular disease.
        Neuroepidemiology: a tribute to Bruce Schoenberg. CRC Press, Boca Raton, FL1991: 27-53 (Anderson, DW Schoenberg, DG eds)
        • Au DH
        • Curtis JR
        • Every NR
        • et al.
        Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction.
        Chest. 2002; 121: 846-851
        • Suissa S
        • Assimes T
        • Ernst P
        Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction.
        Thorax. 2003; 58: 43-46